You are currently viewing a new version of our website. To view the old version click .

Vaccines, Volume 12, Issue 3

March 2024 - 124 articles

Cover Story: Nucleic acid vaccines (i.e., viral vectors, DNA vaccines and mRNA vaccines) provide multiple advantages over other vaccine platforms like subunit proteins or whole-pathogen vaccines. As demonstrated during the SARS-CoV-2 pandemics, their versatility and unique protocols allowed for fast adaptation to novel immunogens. These advantages can benefit the HIV vaccine field that is in dire need of delivery platforms that can be rapidly adapted to a highly mutating virus, while being highly immunogenic. Hence, combining the most relevant HIV immunogens as soluble proteins or those displayed on multivalent platforms with DNA and mRNA systems can pave the way towards the development of HIV vaccines. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (124)

  • Article
  • Open Access
3 Citations
3,511 Views
17 Pages

Analysis of Attitudes and Practices towards the Influenza Vaccine in High-Risk Adults in Poland

  • Dorota Kopciuch,
  • Karolina Hoffmann,
  • Krzysztof Kus,
  • Agnieszka Koligat-Seitz,
  • Piotr Ratajczak,
  • Elżbieta Nowakowska and
  • Anna Paczkowska

21 March 2024

This study aimed to understand Poles’ attitudes and beliefs towards influenza vaccinations in the flu season of 2022–2023, especially among individuals at risk of flu complications. The cross-sectional survey-based study was carried out o...

  • Article
  • Open Access
2 Citations
2,994 Views
17 Pages

Oncolytic Adenovirus Armed with a Novel Agonist of the CD137 Immune Checkpoint Stimulator Suppresses Tumor Growth

  • Martin R. Ramos-Gonzalez,
  • Mohammad Tarique,
  • Lalit Batra,
  • Feyza Arguc,
  • Rodolfo Garza-Morales,
  • Haval Shirwan,
  • Esma S. Yolcu and
  • Jorge G. Gomez-Gutierrez

21 March 2024

Natural 4-1BBL (CD137L) is a cell membrane-bound protein critical to the expansion, effector function, and survival of CD8+ T cells. We reported the generation of an active soluble oligomeric construct, SA-4-1BBL, with demonstrated immunoprevention a...

  • Article
  • Open Access
6 Citations
4,003 Views
20 Pages

Microfluidic Synthesis of Scalable Layer-by-Layer Multiple Antigen Nano-Delivery Platform for SARS-CoV-2 Vaccines

  • Yang Xu,
  • Kazuya Masuda,
  • Christine Groso,
  • Rick Hassan,
  • Ziyou Zhou,
  • Kelsey Broderick,
  • Moriya Tsuji and
  • Christopher Tison

21 March 2024

The COVID-19 outbreak was a global pandemic with wide-ranging healthcare implications. Although several mRNA-based vaccines delivered using lipid nanoparticles (LNP) have been approved and demonstrated efficacy at reducing the severity and spread of...

  • Communication
  • Open Access
5 Citations
2,490 Views
9 Pages

National Immunization Program Decision Making Using the CAPACITI Decision-Support Tool: User Feedback from Indonesia and Ethiopia

  • Maarten Jansen,
  • Dijana Spasenoska,
  • Mardiati Nadjib,
  • Desalegn Ararso,
  • Raymond Hutubessy,
  • Anna-Lea Kahn and
  • Philipp Lambach

20 March 2024

To ensure that limited domestic resources are invested in the most effective interventions, immunization programs in low- and middle-income countries (LMICs) must prioritize a growing number of new vaccines while considering opportunities to optimize...

  • Article
  • Open Access
12 Citations
2,163 Views
13 Pages

20 March 2024

Background: This cross-sectional survey investigated the knowledge, attitudes, and coverage of recommended vaccinations among a random sample of patients with chronic medical conditions, at higher risk of vaccine-preventable diseases (VPDs), in Italy...

  • Article
  • Open Access
6 Citations
2,335 Views
11 Pages

Seroprevalence for Measles, Varicella, Mumps and Rubella in the Trainee Obstetric Population: A Survey in Southern Italy

  • Brunella Perfetto,
  • Giovanna Paduano,
  • Elena Grimaldi,
  • Vincenza Sansone,
  • Giovanna Donnarumma and
  • Gabriella Di Giuseppe

20 March 2024

Background: Despite the efforts of the World Health Organization, some childhood viral diseases, for which there is already an effective vaccine, have not yet been eradicated. Among these, we find varicella, mumps, measles, and rubella, which althoug...

  • Article
  • Open Access
2 Citations
3,236 Views
13 Pages

Baculovirus Vector-Based Varicella-Zoster Virus Vaccine as a Promising Alternative with Enhanced Safety and Therapeutic Functions

  • Chanyeong Lee,
  • Minjee Kim,
  • Jungmin Chun,
  • Sehyun Kim,
  • Doyoung Yoon,
  • Hyeondong Lee,
  • Heewon Bang,
  • Hee-Jung Lee,
  • Hosun Park and
  • Young Bong Kim

20 March 2024

Varicella-zoster virus (VZV) poses lifelong risks, causing varicella and herpes zoster (HZ, shingles). Currently, varicella and HZ vaccines are predominantly live attenuated vaccines or adjuvanted subunit vaccines utilizing VZV glycoprotein E (gE). H...

  • Article
  • Open Access
1 Citations
2,446 Views
10 Pages

The Role of Pharmacists in Counteracting Vaccine Hesitancy: Effectiveness of the 2019 Carnia Project in Improving Adherence to Influenza Vaccination among Target Population

  • Gloria Longobardi,
  • Laura Brunelli,
  • Benedetta Piciocchi,
  • Andrea Morsanutto,
  • Andrea Iob,
  • Flavio Schiava,
  • Claudio Luigi Pancino,
  • Luca Degrassi,
  • Giuseppe Tonutti and
  • Silvio Brusaferro
  • + 1 author

20 March 2024

Vaccine hesitancy has been included among the top ten threats to global health by the World Health Organization. Pharmacists can play a pivotal role in removing the individual barrier to vaccination, because of the relationship of trust they have wit...

of 13

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X